Patents with a poor exercise capacity (<4 METs) represent a high-risk subset, especially if ischemic ECG changes are noted at this low workload. Conversely, patients with a good exercise capacity (>10 METs) often have an excellent prognosis independent of the extent of anatomical CAD. It is estimated that for every 1 met increase in exercise capacity the survival improved by 12%. Failure to reach 85% of predicted exercise capacity was significantly associated with increased risk of MI, unstable angina, coronary revascularization as well as mortality. The association with nonfatal cardiac events suggests that poor exercise capacity is not simply a reflection of a greater burden of comorbidities and worse patient health status.
Zipes, Libby, Bonow, Braunwald.
Armstrong LE, Cerny FJ, Burton.
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr.
Zipes, Libby, Bonow, Braunwald.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE.
Peterson PN, Magid DJ, Ross C, Ho PM, Rumsfeld JS, Lauer MS, Lyons EE, Smith SS, Masoudi FA.
Gulati M, Black HR, Shaw LJ, et al.
Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A.
Patents with a poor exercise capacity (<4 METs) represent a high-risk subset, especially if ischemic ECG changes are noted at this low workload. Conversely, patients with a good exercise capacity (>10 METs) often have an excellent prognosis independent of the extent of anatomical CAD. It is estimated that for every 1 met increase in exercise capacity the survival improved by 12%. Failure to reach 85% of predicted exercise capacity was significantly associated with increased risk of MI, unstable angina, coronary revascularization as well as mortality. The association with nonfatal cardiac events suggests that poor exercise capacity is not simply a reflection of a greater burden of comorbidities and worse patient health status.
Zipes, Libby, Bonow, Braunwald.
Armstrong LE, Cerny FJ, Burton.
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr.
Zipes, Libby, Bonow, Braunwald.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE.
Peterson PN, Magid DJ, Ross C, Ho PM, Rumsfeld JS, Lauer MS, Lyons EE, Smith SS, Masoudi FA.
Gulati M, Black HR, Shaw LJ, et al.
Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
